Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 (PDF)

Name: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 (PDF)
SKU: 101306
Availability: InStock

5 $

Delivery time: Maximum to 1 hours

Format : Publisher PDF

File Size : 22.6 MB

This book discusses the most effective techniques for understanding COVID-19, including genomics, transcriptomics, proteomics, and metabolomics. It explores diagnostics, prognostics, and genomic surveillance, as well as the development of treatments and vaccines. The book is written by an international team of experts and is suitable for researchers, clinical scientists, physicians, drug company scientists, and healthcare workers. It is published by Springer International Publishing and has ISBN numbers 9783031280115 and 9783031280122.

Category: Springer Ebook

Description

Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 (PDF Book)

by Paul C. Guest (Author)

Introduction: The omnipresence of the COVID-19 pandemic has reshaped our perception of global health threats. Even as vaccinations show promise, the global disparity in distribution and the evolution of variants have amplified the urgency to understand and manage SARS-CoV-2 better. A comprehensive approach leveraging advanced omic techniques offers a pathway to achieving this understanding.

Key Features:

Genomic Techniques: Explore the genomic variations of SARS-CoV-2, diving deep into the sequencing methodologies that help identify variants of concern.
Transcriptomics: Understand the transcriptomic changes during the virus’s life cycle, providing insights into viral replication and host interaction.
Proteomics and Metabolomics: Dive into the protein signatures and metabolic alterations brought about by the virus, offering avenues for therapeutic interventions.
Physiological Molecular Assessments: Detailing methodologies to scrutinize the molecular-level impact of the virus on host physiology.
AI in Biomarker Validation: Explore how cutting-edge artificial intelligence tools accelerate the translation of biomarker candidates into viable diagnostic or therapeutic tools.
Global Expertise: Chapters crafted by internationally renowned experts, bringing together a mosaic of global insights on COVID-19 research.

Target Audience: This volume serves a broad spectrum of professionals including:

Biomarker and virology researchers aiming to deepen their understanding of SARS-CoV-2.
Clinicians and healthcare workers needing up-to-date knowledge for patient care.
Drug development scientists seeking to understand potential therapeutic targets.
Academic scholars, students, and professionals in infectious and metabolic disease research.

Conclusion: “Harnessing Omic Techniques: Novel Biomarkers and Drug Targets for COVID-19” is a testament to the potential of integrating advanced techniques in the fight against global health threats. This volume, curated by Paul C. Guest, offers a comprehensive roadmap, shedding light on potential avenues to tackle the COVID-19 pandemic and pave the way for addressing future infectious challenges.